The Polysaccharide Extracted from Umbilicaria esculenta Inhibits Proliferation of Melanoma Cells through ROS-Activated Mitochondrial Apoptosis Pathway

Biological & Pharmaceutical Bulletin
Yanhong SunLiu Yang

Abstract

Melanoma is one of the most aggressive skin cancers with an increasing rate of morbidity. Umbilicaria esculenta is an edible lichen and its main component of extracts-polysaccharide (PUE) has shown significant antitumor effects in a variety of cancer types such as stomach adenocarcinoma. However, whether it has an anti-melanoma effect and the underlying mechanism has not been revealed. In this article, we showed that PUE extracted from Umbilicaria esculenta could inhibit the growth of A875 and A375 melanoma cells but without obvious toxicity to normal vascular endothelial cells. The generation of reactive oxygen species (ROS) in A875 cells was significantly elevated when treated with PUE for 24h. In addition, the expression of caspase-3 and -9 also increased as compared to the controlled group which resulted in the apoptosis of A875 melanoma cells. In the meantime, when pre-treated with N-acetylcysteine (NAC), the ROS scavenger, PUE induced apoptosis and cell death could be reversed via suppression of elevated generation of ROS and ROS-mediated caspase-9 expression. In summary, our study demonstrated that PUE extracts from Umbilicaria esculenta have a potent anti-melanoma effect through the induction of ROS and caspases-3 and -...Continue Reading

References

Dec 3, 1998·Melanoma Research·F BittingerC J Kirkpatrick
Mar 31, 2000·Experimental Cell Research·S H Kaufmann, W C Earnshaw
Oct 26, 2000·Nature·M O Hengartner
Dec 8, 2000·Canadian Journal of Microbiology·K A Lee, M S Kim
Jun 6, 2003·The British Journal of Dermatology·C S SanderJ J Thiele
Dec 31, 2005·Journal of Ethnopharmacology·Moo-Sung Kim, Kyung-Ae Lee
Jan 23, 2008·Biological Chemistry·Catharina Bertram, Ralf Hass
Jan 5, 2010·Free Radical Biology & Medicine·Magdalena L Circu, Tak Yee Aw
Feb 3, 2011·Immune Network·Hyung Sook KimSang-Bae Han
Jun 4, 2011·Biochemical Pharmacology·Inna V FedorenkoKeiran S M Smalley
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Aug 25, 2011·Journal of Medicinal Food·Marijana Kosanić, Branislav Ranković
Dec 31, 2011·Molecules and Cells·Yun Soo BaeYoung Do Yoo
Jan 21, 2012·Journal of Food Science·Marijana KosanićTatjana Stanojković
Jan 8, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ryan J Sullivan, Keith T Flaherty
Jul 10, 2013·BMC Cell Biology·Matthew BrentnallLawrence H Boise
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 2, 2014·Journal of Managed Care Pharmacy : JMCP·Anthony J Olszanski
Apr 9, 2014·Carbohydrate Polymers·Yufeng WangYangyang Chen
Jun 19, 2014·International Journal of Medicinal Mushrooms·Baojun XuChangkeun Sung
Oct 16, 2014·International Journal of Biological Macromolecules·Yi-Qun DuJun-Hui Wang
Jan 1, 2015·Nature Reviews. Disease Primers·Dirk SchadendorfAxel Hauschild

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis